Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeri Kim

Showing results (31-40 of 103) with videos related to

Pageof 11
Sort By:
Carcinogenesis|August 13, 2016
Genetic variants of the Wnt signaling pathway as predictors of aggressive disease and reclassification in men with early stage prostate cancer on active surveillanceXiang Shu, Yuanqing Ye, Jian Gu, et al.
British Journal of Cancer|January 26, 2019
Diet quality and Gleason grade progression among localised prostate cancer patients on active surveillanceJustin R Gregg, Jiali Zheng, David S Lopez, et al.
Anticancer Research|November 3, 2004
High efficacy of docetaxel with and without androgen deprivation and estramustine in preclinical models of advanced prostate cancerKarim Fizazi, Charles R Sikes, Jeri Kim, et al.
The Journal of Urology|September 5, 2018
Coffee, Caffeine Metabolism Genotype and Disease Progression in Patients with Localized Prostate Cancer Managed with Active SurveillanceJustin R Gregg, David S Lopez, Chad Reichard, et al.
Plos One|December 24, 2011
Androgen regulation of 5α-reductase isoenzymes in prostate cancer: implications for prostate cancer preventionJin Li, Zhiyong Ding, Zhengxin Wang, et al.
Carcinogenesis|March 28, 2020
Genetic variants in epithelial-mesenchymal transition genes as predictors of clinical outcomes in localized prostate cancerYang Deng, Kunlin Xie, Christopher J Logothetis, et al.
The Journal of Pathology|May 14, 2004
Up-regulation of MDA-BF-1, a secreted isoform of ErbB3, in metastatic prostate cancer cells and activated osteoblasts in bone marrowFunda Vakar-Lopez, Chien-Jui Cheng, Jeri Kim, et al.
International Journal of Oncology|August 17, 2012
Arachidonic acid metabolism in human prostate cancerPeiying Yang, Carrie A Cartwright, Jin Li, et al.
Clinical Genitourinary Cancer|August 10, 2021
Beyond Frontline Therapy with Abiraterone and Enzalutamide in Metastatic Castration-Resistant Prostate Cancer: A Real-World US StudyNeal D Shore, Raluca Ionescu-Ittu, François Laliberté, et al.
JAMA Network Open|November 15, 2024
Racial and Ethnic Differences in Prostate Cancer Epidemiology Across Disease States in the VAShannon R Stock, Michael T Burns, Justin Waller, et al.
Pageof 11

Showing results (31-40 of 103) with videos related to

Sort By:
Pageof 11
Carcinogenesis|August 13, 2016
Genetic variants of the Wnt signaling pathway as predictors of aggressive disease and reclassification in men with early stage prostate cancer on active surveillanceXiang Shu, Yuanqing Ye, Jian Gu, et al.
British Journal of Cancer|January 26, 2019
Diet quality and Gleason grade progression among localised prostate cancer patients on active surveillanceJustin R Gregg, Jiali Zheng, David S Lopez, et al.
Anticancer Research|November 3, 2004
High efficacy of docetaxel with and without androgen deprivation and estramustine in preclinical models of advanced prostate cancerKarim Fizazi, Charles R Sikes, Jeri Kim, et al.
The Journal of Urology|September 5, 2018
Coffee, Caffeine Metabolism Genotype and Disease Progression in Patients with Localized Prostate Cancer Managed with Active SurveillanceJustin R Gregg, David S Lopez, Chad Reichard, et al.
Plos One|December 24, 2011
Androgen regulation of 5α-reductase isoenzymes in prostate cancer: implications for prostate cancer preventionJin Li, Zhiyong Ding, Zhengxin Wang, et al.
Carcinogenesis|March 28, 2020
Genetic variants in epithelial-mesenchymal transition genes as predictors of clinical outcomes in localized prostate cancerYang Deng, Kunlin Xie, Christopher J Logothetis, et al.
The Journal of Pathology|May 14, 2004
Up-regulation of MDA-BF-1, a secreted isoform of ErbB3, in metastatic prostate cancer cells and activated osteoblasts in bone marrowFunda Vakar-Lopez, Chien-Jui Cheng, Jeri Kim, et al.
International Journal of Oncology|August 17, 2012
Arachidonic acid metabolism in human prostate cancerPeiying Yang, Carrie A Cartwright, Jin Li, et al.
Clinical Genitourinary Cancer|August 10, 2021
Beyond Frontline Therapy with Abiraterone and Enzalutamide in Metastatic Castration-Resistant Prostate Cancer: A Real-World US StudyNeal D Shore, Raluca Ionescu-Ittu, François Laliberté, et al.
JAMA Network Open|November 15, 2024
Racial and Ethnic Differences in Prostate Cancer Epidemiology Across Disease States in the VAShannon R Stock, Michael T Burns, Justin Waller, et al.
Pageof 11